Lung Ambition Alliance invites member organisations to apply for grant to support projects
Patient and caregiver non-profit organisations are now invited to submit proposals to ILC2, a grant opportunity for projects that go beyond prevention to support people with lung cancer at different stages of diagnosis.
The ILC2 initiative has been created in recognition of the high variation in lung cancer management around the world, and the very specific local barriers to quality care that must be considered when developing patient centric solutions to address them.
Learn more here
You can access and download the Lung Ambition Alliance ILC2 fact sheet here and Guidance for Applicants here.
Please review the guidance before starting your application. Applications require the completion of an online form, which must be submitted by 31 January 2020 on the separate application portal on the ILC2 website.
ILC2 grant applications will be reviewed and selected by the four founding partners of the Lung Ambition Alliance; the Global Lung Cancer Coalition, Guardant Health, the International Association for the Study of Lung Cancer and AstraZeneca. Funding for the ILC2 grant is provided by AstraZeneca.
